Detalhe da pesquisa
1.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
N Engl J Med
; 389(20): 1851-1861, 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870969
2.
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.
Lancet
; 403(10431): 1061-1070, 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402886
3.
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.
Histopathology
; 84(6): 947-959, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253940
4.
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study.
Cancer
; 129(8): 1195-1204, 2023 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748723
5.
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival.
Eur J Nucl Med Mol Imaging
; 49(7): 2401-2413, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149914
6.
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors.
Neuroendocrinology
; 112(6): 537-546, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348346
7.
Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective study.
Support Care Cancer
; 31(1): 41, 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525139
8.
Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?
Neuroendocrinology
; 111(1-2): 139-145, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-31639792
9.
Long-Term Results after Surgical Resection of Peritoneal Metastasis from Neuroendocrine Tumors.
Neuroendocrinology
; 111(6): 599-608, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32512564
10.
Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series.
BMC Nephrol
; 21(1): 35, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32000700
11.
Correction to: Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series.
BMC Nephrol
; 21(1): 44, 2020 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32039708
12.
Occult Contralateral Lateral Lymph Node Metastases in Unilateral N1b Papillary Thyroid Carcinoma.
World J Surg
; 43(3): 818-823, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30465086
13.
Randomised controlled trials are feasible in anaplastic thyroid cancer.
Lancet Oncol
; 24(2): 119-121, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681090
14.
Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT.
Eur J Nucl Med Mol Imaging
; 45(10): 1772-1780, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29680989
15.
Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
Int J Gynecol Cancer
; 25(2): 296-302, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25581897
16.
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
Int J Cancer
; 135(11): 2711-20, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24752622
17.
Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: a retrospective and observational study.
Endocrine
; 83(1): 150-159, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37639174
18.
Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network.
J Nucl Med
; 65(2): 258-263, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212066
19.
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
Thyroid
; 34(1): 26-40, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009200
20.
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
Thyroid
; 34(2): 167-176, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37842841